Category Archives: MS Treatment

The FDA ruling could impact the value of Sanofi's Genzyme takeover, since the latter's shareholders had received so-called contingent value rights (CVRs) entitling them to future payments of up to $14 a share if certain goals were met. Sanofi said on Monday it did not expect to meet the CVR milestone of U.S. approval for Lemtrada by the end of March. Other milestones are related to the drug's sales and would likely be hard to reach without the U.S. market. Analysts on average had expected Lemtrada to generate annual sales of $707 million by 2018, according to forecasts compiled by Thomson Reuters. "Genzyme's takeover was about catching up in biologics, having a greater footprint in the United States, and also largely for Lemtrada,'' said Eric Le Berrigaud, analyst at Bryan Garnier & Co. "This is unquestionably a setback, as without a U.S. market such a product doesn't have the same potential.'' Costly Process The brokerage, which had forecast peak Lemtrada sales of $400 million in the United States, said it was scrapping the U.S. market from its forecasts. It argued it would take Sanofi at least three years to conduct the studies demanded by the FDA, and that, given an … Continue reading →

December 30, 2013 The Food and Drug Administration (FDA) has rejected French drugmaker Sanofis multiple sclerosis (MS) treatment called Lemtrada, the company announced on Monday. The rejection is considered a serious blow to the company, which had the drug recently approved by other regulatory bodies. The FDA did not approve the drug on the grounds that the Sanofi-owned developer Genzyme had not demonstrated that its medical benefits offset its serious adverse effects, Sanofi said in a statement. FDA has also taken the position that one or more additional active comparator clinical trials of different design and execution are needed prior to the approval of Lemtrada, the company added. Sanofi went on to say that it disagreed with the FDA ruling and planned to appeal it.The same drug was approved by EU regulators in September as well as by Canadian and Australian regulators more recently. Alemtuzumab, the active ingredient in the drug, targets a specific immune system protein and reorganizes immune system cells. The result is a significant suppression of inflammatory activity in patients with MS. Clinical trials showed that alemtuzumab was better than beta-interferons, a standard drug for relapsing-remitting MS. Some clinical evidence even found that it slowed the progression … Continue reading →

Denver, Colorado (PRWEB) December 29, 2013 SclerosisTreatment.com talks about this new method as one of the best natural treatments for MS at the moment. In its Multiple Sclerosis Natural Treatment review, the website reveals that patients dealing with this condition have so many disturbing symptoms that finding a quick and effective way to overcome the disease is a must. To find out more about this new natural treatment read the full review at: http://www.sclerosistreatment.com/2013/02/multiple-sclerosis-natural-treatment.html Symptoms of MS are going to vary depending on the location of the affected nerves. They can include dizziness, fatigue, weakness, numbness, tremor, but also vision problems, lack of coordination and slurred speech. For a complete list go to: http://www.mssociety.org.uk/what-is-ms/signs-and-symptoms One of the most important reasons why the Multiple Sclerosis Natural Treatment program is so appreciated is the fact that it targets the cause of MS to overcome it. When the cause is gone, symptoms will gradually disappear. Well, the creator of this new healing method claims that the real cause of MS is a damaged immune system. When the immune system is damaged, it attacks and destroys the sheaths that cover nerves, causing all the aforementioned symptoms. Dr. Gary M. Levin, the author of the … Continue reading →

The term alternative therapy, in general, is used to describe any medical treatment or intervention that has not been scientifically documented or identified as safe or effective for a specific condition. Alternative therapy encompasses a variety of disciplines that range from diet and exercise to mental conditioning to lifestyle changes. Examples include acupuncture, yoga, aromatherapy, relaxation, herbal remedies, and massage. MS and Your Diet: Is There a Link? Many foods have been touted as helpful for people with multiple sclerosis (MS). Do they work? "There are strong reasons to think that diet could affect MS symptoms and even help treat it," says neurologist Ellen Mowry, MD, of Johns Hopkins University. But although a healthy diet is always a good idea, there is no proof that any diet or food, on its own,treats MS. If you want to try changing your diet to see if it helps your MS, do your homework. Make sure you've got good information from a reliable... Read the MS and Your Diet: Is There a Link? article > > Complementary therapies are alternative therapies used in addition to traditional treatments. For example, you may have weekly massages to complement your drug treatment. The rest is here: … Continue reading →

London scientists have made a breakthrough fighting the scourge of multiple sclerosis, fine-tuning MRIs to detect the disease before it ravages its victims. This could be a real game-changer, said Dr. Bruce Bebo, who this year will decide how to invest $50million in research raised by the National MS Society in the United States. Bebo marvelled Thursday from afar at the work of a London research team headed by Dr. Ravi Menon thats aimed at what has been an elusive target finding and treating MS before it causes physical and cognitive impairment. The challenge is especially pressing in Canada, where MS rates are the highest in the world nine times higher than the world average. Neurologists have long used MRIs to diagnose MS by showing damage to the protective sheath that insulates the bodys central nervous system. Now, London researchers have fine-tuned a high-powered MRI to actually measure the amount of damage to that protective sheath called myelin as well as the deposits of iron typically found with the disease. The team from Western University perfected the scans first on rats in a study published this month in the journal Proceedings of the National Academy of Sciences. Its a huge … Continue reading →

OAKLAND, Calif. (AP) A judge on Tuesday ruled that a 13-year-old Northern California girl declared brain dead after suffering complications following a tonsillectomy can be taken off life support. But Alameda County Superior Court Judge Evelio Grillo gave Jahi McMath's family until 5 p.m. Dec. 30 to file an appeal. She will stay on life support until then. Relatives said the family has not decided if they would keep fighting. "It's Christmas Eve, there is still time for a miracle," said Omari Sealey, the girl's uncle. He said the family would discuss and decide later whether to appeal or to allow Children's Hospital of Oakland to remove the girl from a ventilator. "Prayers are more important than ever before," Sealey said. "Because the clock is ticking." Jahi's mother, Nailah Winkfield, didn't attend the court hearing, remaining with her daughter in the hospital where she will spend Christmas Eve. Sealey said Winkfield and other family members have remained with the teen since complications arose Dec. 9 after a tonsillectomy. "Room 325 of Children's Hospital is our new home," Sealey said. Sealey held hands with Jahi's grandmother Sandra Chatman, Jahi's stepfather Martin Winkfield and the family's lawyer Christopher Dolan as the judge … Continue reading →

OAKLAND, Calif. (AP) A Northern California family who lost their bid to keep their 13-year-old daughter on life support says "there is still time for a miracle." Alameda County Superior Court Judge Evelio Grillo has ruled that Jahi McMath, who was declared brain dead after suffering complications following a tonsillectomy, can be removed from the ventilator keeping her body functioning. But the judge gave Jahi's family until 5 p.m. Dec. 30 to file an appeal. Until then, she will stay on life support at Children's Hospital Oakland. Relatives said the family has not decided if they would keep fighting. "There is still time for a miracle," said Omari Sealey, the girl's uncle, said Tuesday. He said the family would decide later whether to appeal or to allow the hospital to remove the girl from a ventilator. "Prayers are more important than ever before," Sealey said. "Because the clock is ticking." Jahi's mother, Nailah Winkfield, didn't attend the court hearing Tuesday, staying by her daughter's side in the hospital. Sealey said Winkfield and other family members have remained with the teen since complications arose Dec. 9 after a tonsillectomy. "Room 325 of Children's Hospital is our new home," Sealey said. Sealey … Continue reading →

OAKLAND, Calif. (AP) A judge on Tuesday ruled that a 13-year-old Northern California girl declared brain dead after suffering complications following a tonsillectomy can be taken off life support. But Alameda County Superior Court Judge Evelio Grillo gave Jahi McMath's family until 5 p.m. Dec. 30 to file an appeal. She will stay on life support until then. Relatives said the family has not decided if they would keep fighting. "It's Christmas Eve, there is still time for a miracle," said Omari Sealey, the girl's uncle. He said the family would discuss and decide later whether to appeal or to allow Children's Hospital of Oakland to remove the girl from a ventilator. "Prayers are more important than ever before," Sealey said. "Because the clock is ticking." Jahi's mother, Nailah Winkfield, didn't attend the court hearing, remaining with her daughter in the hospital where she will spend Christmas Eve. Sealey said Winkfield and other family members have remained with the teen since complications arose Dec. 9 after a tonsillectomy. "Room 325 of Children's Hospital is our new home," Sealey said. Sealey held hands with Jahi's grandmother Sandra Chatman, Jahi's stepfather Martin Winkfield and the family's lawyer Christopher Dolan as the judge … Continue reading →

OAKLAND, Calif. (AP) A judge on Tuesday ruled that a 13-year-old Northern California girl declared brain dead after suffering complications following a tonsillectomy can be taken off life support. But Alameda County Superior Court Judge Evelio Grillo gave Jahi McMath's family until 5 p.m. Dec. 30 to file an appeal. She will stay on life support until then. Relatives said the family has not decided if they would keep fighting. "It's Christmas Eve, there is still time for a miracle," said Omari Sealey, the girl's uncle. He said the family would discuss and decide later whether to appeal or to allow Children's Hospital of Oakland to remove the girl from a ventilator. "Prayers are more important than ever before," Sealey said. "Because the clock is ticking." Jahi's mother, Nailah Winkfield, didn't attend the court hearing, remaining with her daughter in the hospital where she will spend Christmas Eve. Sealey said Winkfield and other family members have remained with the teen since complications arose Dec. 9 after a tonsillectomy. "Room 325 of Children's Hospital is our new home," Sealey said. Sealey held hands with Jahi's grandmother Sandra Chatman, Jahi's stepfather Martin Winkfield and the family's lawyer Christopher Dolan as the judge … Continue reading →

Opexa intends to use the net proceeds from the offering to continue funding the ongoing Abili-T clinical study of Tcelna in patients with Secondary Progressive MS and for general corporate purposes (including working capital, research and development, business development and operational purposes). Aegis Capital Corp. acted as sole book-running manager for the offering. The offering was made pursuant to a shelf registration statement on Form S-3 that was filed by Opexa with the Securities and Exchange Commission (SEC) and declared effective by the SEC on December5, 2012. Copies of the prospectus supplement relating to and describing the terms of the offering are available on the SECs web site at http://www.sec.gov. Copies of the prospectus supplement relating to these securities may also be obtained from the offices of Aegis Capital Corp., Prospectus Department, 810 Seventh Avenue, 18thFloor, New York, NY, 10019, via telephone at (212) 813-1010, or via email at prospectus@aegiscap.com. This press release does not constitute an offer to sell or the solicitation of an offer to buy these securities, nor will there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale is not permitted. About Opexa Opexas mission is … Continue reading →